Specific combinations of antihypertensives are recommended for patients with Bruton’s tyrosine kinase inhibitor (BTKi)-associated hypertension (HTN), according to a study published online Feb. 5 in Blood Advances.
Specific combinations of antihypertensives are recommended for patients with Bruton’s tyrosine kinase inhibitor (BTKi)-associated hypertension (HTN), according to a study published online Feb. 5 in Blood Advances.
Leave A Comment